SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001564590-20-053711
Filing Date
2020-11-13
Accepted
2020-11-13 06:03:52
Documents
4
Period of Report
2020-11-13

Document Format Files

Seq Description Document Type Size
1 6-K/A asln-6ka_20201113.htm 6-K/A 23718
2 EX-99.1 asln-ex991_6.htm EX-99.1 388120
3 GRAPHIC gacisgzgx2pq000001.jpg GRAPHIC 194726
4 GRAPHIC gacisgzgx2pq000003.jpg GRAPHIC 9744
  Complete submission text file 0001564590-20-053711.txt   694621
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-38475 | Film No.: 201309029
SIC: 2834 Pharmaceutical Preparations